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Background: DNA fragments carrying internal recognition sites for the restriction endonucleases intended for
cloning into a target plasmid pose a challenge for conventional cloning.
Results: A method for directional insertion of DNA fragments into plasmid vectors has been developed. The target
sequence is amplified from a template DNA sample by PCR using two oligonucleotides each containing a single
deoxyinosine base at the third position from the 5′ end. Treatment of such PCR products with endonuclease V generates
3′ protruding ends suitable for ligation with vector fragments created by conventional restriction endonuclease reactions.
Conclusions: The developed approach generates terminal cohesive ends without the use of Type II restriction
endonucleases, and is thus independent from the DNA sequence. Due to PCR amplification, minimal amounts of
template DNA are required. Using the robust Taq enzyme or a proofreading Pfu DNA polymerase mutant, the method is
applicable to a broad range of insert sequences. Appropriate primer design enables direct incorporation of terminal DNA
sequence modifications such as tag addition, insertions, deletions and mutations into the cloning strategy. Further, the
restriction sites of the target plasmid can be either retained or removed.
Keywords: Cohesive ends, DNA cleavage, Genetic vectors, Modified primers, Molecular methods, Polymerase chain
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With hundreds of enzymes commercially available today
[1], restriction endonuclease treatment of insert and plas-
mid vector DNA followed by ligation and transformation
into competent E. coli strains presents the standard cloning
method in molecular biology. Given the advances in struc-
tural biology and the advent of synthetic biology, a strong
demand exists to transfer and rearrange a large variety of
DNA fragments from different genetic sources in a directed
manner. A diverse catalogue of plasmid vectors is at hand
for propagation in pro- and eukaryotic cells, enabling
heterologous protein expression in various host organisms.
Frequently, suitable pairs of Type II restriction enzymes
with unique recognition sites in the vector and insert DNA
fragments can be found, especially since the latter are easily
produced via PCR. In such a case, the PCR primers contain* Correspondence: kristian@syntbio.net
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reproduction in any medium, provided the oradd-on tails composed of the restriction endonuclease
recognition sequence and additional nucleotides which
ensure efficient enzymatic processing [2]. Especially with
an increasing size of the insert, however, the chance rises
that it contains a recognition site of the desired restriction
enzymes. Statistically, the 6 bp recognition sequence of a
Type II restriction enzyme such as XbaI would occur once
in every 46 / 2 = 2048 base pairs. The situation gets worse if
one aims to insert multiple sequences in dual-expression
vectors, as for instance required for co-expression studies
in metabolic engineering, structural and synthetic biology
[3-6]. These circumstances require purchase and storage
of numerous restriction enzymes or the execution of
site-directed mutagenesis (including design and synthesis/
purchase of mutagenic primers, high-fidelity PCR, trans-
formation and sequencing) [7,8] in order to remove the un-
wanted recognition sites. Individual buffer and temperature
requirements for endonuclease stability and activity [9]
further limit the number of cloning options.ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Cohesive dsDNA ends created in this study. In order to
ligate insert DNA fragments efficiently with a linearized target
plasmid vector, both molecules have to carry compatible cohesive
ends. For the vector DNA, 5′ recessed ends are created by
conventional restriction enzyme treatment. Names and recognition
sequences of the enzymes used in this study are listed. For other
enzymes, please refer to REBASE [60]. Endonucleolytic cleavage
positions are depicted as vertical dashes. Insert DNA fragments with
compatible cohesive ends are created by PCR and subsequent
endonuclease V treatment (as illustrated in Figure 2). The 5′ ends of
the PCR primers and the termini of the corresponding PCR products
differ from the shown sequences: They lack the first nucleotide
(shown in red) and carry deoxyinosine instead of the residue shown
in orange. EndoV treatment of the PCR product results in 5′
recessed ends shown in bold letters with yellow background. If the
residue highlighted in grey is omitted from the oligonucleotide
design, ligation of the insert fragments with linearized plasmid DNA
does not reconstitute the restriction enzyme site.
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methods avoiding the use of Type II restriction enzymes
have been developed. The Gateway cloning system relies
on site-specific recombination catalyzed by a proprietary
bacteriophage λ protein formulation in vitro [10]. Creation
of large recombinant DNA molecules can be achieved by
the domino method [11] and DNA assembler [12], which
are based on homologous recombination in vivo by the
machinery of B. subtilis or S. cerevisiae, respectively. The
endogenous recombination system of E. coli can combine
insert and vector molecules upon co-transfection [13,14],
which can be facilitated by expression of a homing endo-
nuclease and bacteriophage recombinases [15]. Similarly,
a cell lysate which contains a prophage recombination
system can be used in vitro [16]. PCR-based generation of
complete recombinant plasmids, preferably via a proofread-
ing DNA polymerase, can be achieved by several strategies
[17-21]. For the highly complex challenge of genome
engineering, homing nucleases [22], transcription activator
like (TAL) [23] and zinc-finger nucleases [24] can be used.
More similar to the conventional restriction-ligation
system, compatible cohesive ends can be generated in
alternative ways. Combined with a subsequent ligation
reaction that stabilizes the paired ends, exonuclease III [25]
or T4 DNA polymerase [26] can be used for their creation.
Ligation-independent cloning (LIC) [27] employs lon-
ger overhangs resulting in sufficiently stable DNA base
pairing for transformation. These can be created by
several means, e.g. via T4 DNA polymerase or incom-
plete PCR [27-29], hybridization of PCR products [30],
ribonucleotide-containing primers [31], terminal transfer-
ase [32], abasic sites [33], chemical or enzymatic cleavage
of phosphorothioated DNA [34,35], or λ exonuclease [36].
Elegant enzyme-based in vitro systems have been devel-
oped, such as In-Fusion cloning [37], for which the poly-
merase is known but not the exact composition, as well as
the combined isothermal usage of a DNA polymerase, a
5′ exonuclease and DNA ligase, named Gibson assembly
cloning [38]. Although several of the described cloning
systems with individual advantages and disadvantages are
commercially available, many present costly alternatives
or demand complex planning.
Smith et al. reported a method to create insert frag-
ments with 5′ recessed ends via PCR, utilizing deoxyuracil-
containing primers [39]. Treatment of the PCR products
with heat or alkaline solution creates 3′ overhangs compat-
ible with those of the vector fragment. In a similar fashion,
USER friendly DNA cloning [40] utilizes a commercially
available enzyme mix. In contrast to uracil DNA glycosylase
(UDG) treatment, this enzyme mix removes the dU resi-
dues instead of cleaving the N-glycosylic bond. Compatible
vectors are generated by treating the plasmid DNA with
a nicking and a Type II restriction endonuclease instead
of PCR-based amplification. As for other methods, thisstrategy avoids the risk of introducing polymerase errors
into the plasmid backbone. Although cohesive ends can
also be generated by using DNA glycosylase-lyase Endo VIII
[41] or Endo IV [42] subsequent to UDG, we sought to de-
velop a more straightforward cloning method that requires
only one enzyme, no heat- or alkaline treatment and which
allows the creation of more 3′ protruding end combinations
(see Figure 1 for those created in this study).
Unlike deoxyuracil, the universal base deoxyinosine (dI)
can pair with all four canonical DNA nucleobases following
a duplex stability series of I:C > I:A > I:T≈I:G [43]. In
contrast to several proofreading polymerases [44], Taq
polymerase can incorporate dITP during primer extension
and readily extends dI-containing DNA. These properties
allow deoxyinosine usage for the creation of degenerate
primers [45,46] as well as for random [47] and sequence
saturation mutagenesis [48].
With deoxyinosine-containing oligonucleotides and
endonuclease V (EndoV) readily available from commercial
suppliers, a method was developed to create terminal 3′
protruding ends independent of the insert DNA sequence
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quence enables the directional insertion of DNA fragments
into plasmid vectors by PCR, endonuclease V treatment
and ligation. In order to avoid the introduction of polymer-
ase errors, linearized vectors are created using conventional
restriction endonucleases. The applicability of the system is
demonstrated by successful cloning of three different cod-
ing sequences into several plasmid vectors with efficiencies
matching or exceeding those of alternative approaches.
Results and discussion
Non-directional ampicillin resistance cassette cloning
In order to establish the proof of concept, the oligonucleo-
tides pUCamp_f and pUCamp_r (Table 1) were designed
for the amplification of a 1114 bp region from plasmidFigure 2 Scheme for the generation of cohesive ends. In addition to regi
designed with overhangs comprising the 4 bp cohesive part of a restriction s
end. Primer annealing and extension during a PCR leads to amplification of th
(bold, orange) in its termini. The pairing properties of the universal base will g
opposing strand (indicated as ‘N’). Purified PCR products are treated with End
target DNA fragment (4) is obtained by spin column-based or agarose gel pu
Carrying cohesive ends with 5′ phosphates, the insert fragment is now suitab
restriction enzyme treatment (in the depicted case SacI and KpnI).pUC18. Insertion of this DNA sequence into a different
plasmid vector was expected to confer ampicillin resist-
ance to transformed E. coli cells, allowing straightforward
detection of recombinant clones. The target sequence in-
cludes the P3 promoter [49], the ribosome binding site,
the β-lactamase (bla) coding region and the terminal TAA
stop codon. Both oligonucleotides were designed to form
primer-template duplexes with Tm values of 56–57°C. In
order to enable cloning, the 5′ primer ends comprise four
additional nucleotides with a deoxyinosine residue at the
third position (compare Figure 1). According to previous
reports and the crystal structure of the Thermotoga
maritima (Tma) enzyme [50], treatment of the PCR
products with endonuclease V was expected to result
in hydrolysis of the second phosphodiester bond 3′ to dIons complementary to the insert DNA sequence (1), oligonucleotides are
ite combined with deoxyinosine (dI) at the third position from the 5′
e desired target fragment (2), which carries the dI residues
enerate a sequence distribution at the corresponding site of the
oV, which cleaves the second phosphodiester bond 3′ to dI (3). The
rification, respectively, removing the weakly bound residues of ssDNA.
le for ligation to vector DNA fragments created by conventional
Table 1 Oligonucleotide sequences
Oligonucleotide Sequence (5′ - 3′)
pUCamp_f GTICC TATGAGTAAACTTGGTCTGACAGTTACC
pUCamp_r GTICC GTCATCACCGAAACGCGCG
RFP-dev_f TGIAG GCGCAACGCAATTAATGTGAG
RFP-dev_r ACITC GTTATTAAGCACCGGTGGAGTG
MITF_f AGITC ATGCTGGAAATGCTAGAATACAG
MITF_r GTICCTCA ACACGCATGCTCCGTTTCTTC
Mitf-FL_f CATGCTAGCATGCTGGAAATGCTAGAATACAGTC
VR2_r ATTACCGCCTTTGAGTGAGC
Deoxyinosine residues are shown in bold, primer add-on tails are underlined
and separated from regions complementary to the target sequences
by spaces.
1200 bp 1200 bp
-3 Tm +3 Tm +3A B
Figure 3 Robust PCR-amplification of insert DNA fragments
using deoxyinosine-containing primers. Analytical agarose gel
electrophoresis of PCR products produced by Taq polymerase using
either plasmid DNA (A) or E. coli colonies (B) as template material.
Relative to the calculated Tm, annealing temperatures used for PCR
cycling are indicated for each lane.
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creates cohesive ends compatible with those generated by
the restriction enzyme KpnI. Figure 2 illustrates a similar
case of cohesive end creation, whereas the design of the
forward primer results in an overhang compatible with that
of a different Type II restriction enzyme (see Figure 1 for
all cohesive ends created in this study). It should be noted
that the base-pairing properties of dI [43] will generate
a sequence distribution at the corresponding position
on the opposing strand of the PCR-generated dsDNA,
which is discussed in the Conclusions section.
With the two synthetic oligonucleotides, PCR was
conducted using Taq DNA polymerase and a total of
27 amplification cycles. Subsequent to DNA purification,
endonuclease V treatment and preparative agarose gel
electrophoresis were performed. Ligation reactions were
prepared with KpnI-digested and dephosphorylated
pIRES2-EGFP or pSB1C3, respectively. Next, competent
E. coli XL-1 Blue cells were transformed. After overnight
incubation at 37°C, clones were found to grow on LB agar
plates supplemented with ampicillin in addition to either
kanamycin or chloramphenicol, respectively. Accordingly,
the insert DNA was successfully integrated into the vector
backbone and the amplified antibiotic resistance cassette
(AmpR) was functional in vivo.
PCR was repeated with an annealing temperature gradi-
ent spanning Tm ± 3°C. As shown in Figure 3A, products
of the expected size were formed in all cases with
comparable quantities. Other, non-specific bands were not
detected. Consequently, the presence of the dI-containing
overhang did not hinder binding of the primers to the
complementary plasmid DNA. This is consistent with earl-
ier studies [52]. To test whether E. coli colonies can serve
as a direct source for the target DNA, colony PCR was
performed using XL-1 Blue cells transformed with the
template plasmid. Cycling and reaction conditions
were kept identical except for the initial denaturation,
which was extended to 3 min to facilitate cell disruption
and DNA release. Figure 3B shows that specific PCRproducts undistinguishable from those created by amplifi-
cation from plasmid DNA were formed.
While simple co-transfection of vector and insert DNA
fragments, each with large homologous regions (> 10 bp)
at both ends, can create recombinant plasmids [13,14],
we found no recombinant clones when the endonuclease
V treatment of the insert DNA was omitted. Ligation
reactions performed with only insert or vector DNA,
respectively, also did not yield ampicillin-resistant clones.Directional cloning of a RFP reporter device
Since functional selection for the insertion of the ampicillin
resistance cassette into plasmid vectors (previous chapter)
did not yield information about the background of erro-
neous, empty or incomplete ligation events, a screening
method for positive clones was employed. The red fluores-
cent protein (RFP) coding device BioBrick BBa_J04450
was chosen since mRFP1 expression by E. coli is easily
detected [53]. Primers RFP-dev_f and RFP-dev_r (Table 1)
were used to amplify an 830 bp region which comprises
the E. coli lactose (lac) operon promoter including CAP
and RNA polymerase binding sites, a ribosome binding
site and a coding region for mRFP1 followed by a double
TAA stop codon. The Tm value of the primer-template
duplexes was 53–55°C. A total of 31 cycles were used
for Taq polymerase-based amplification. After treatment
with 5 u of Tma endonuclease V, a ligation reaction with
dephosphorylated pUC19 digested with AatII and PstI
was set up using a molar insert to vector ratio of 7:1.
Transformation of E. coli XL-1 Blue yielded 252 colonies,
of which 233 were classified as RFP-positive by manual
counting (see Figure 4). Five apparently RFP-negative
clones were used to inoculate 5 mL LB medium containing
Figure 4 mRFP1-positive clones obtained by cloning an RFP-coding device into pUC19. Recombinant E. coli colonies expressing mRFP1.
Detection was facilitated via excitation at 505 nm. Manual counting yielded a positive fraction (dark blue markers) of about 92.4% (233 of 252 colonies),
cyan markers present negative colonies with poor or no fluorescence.
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and 200 rpm, the liquid cultures possessed no or only
slightly red color, respectively. DNA sequencing revealed
that all clones carried an RFP coding device insert.
Evidently, the observed low or missing red fluorescence
was caused by point mutations or single base pair
deletions in the mRFP1 coding sequence. Given the high
number of PCR cycles used to produce the insert DNA
fragment, this outcome was not unexpected. Assuming a
constant amplification fidelity, the range of reported Taq
polymerase error rates of 8 × 10-6 - 2 × 10-4 [54,55] corre-
sponds to a fraction of 25.7 - 100% PCR products with
one or more base substitutions. In addition, plasmid DNA
from seven fluorescent clones was sequenced. One clone
carried two mutations of which one was silent; another
clone carried one silent mutation. Five clones were free of
mutations in the mRFP1 coding region. This corresponds
to a total error rate of about 6 × 10-4, which fits
the expected range (see above). Based on the frequencyof RFP-positive clones, the efficiency of RFP-device
insertion into the plasmid vector was ≥ 92.4%.
Directional cloning of an eukaryotic coding sequence
To further explore the capabilities and limits of the cloning
method, we chose to amplify the coding region of the Mus
musculus microphthalmia-associated transcription factor
(Mitf). The oligonucleotides MITF_f and MITF_r (Table 1)
were designed for the amplification of a 1270 bp DNA
fragment. The regions complementary to the template mol-
ecule were 24 or 21 bp in length, respectively, and a TGA
stop codon was introduced via an overhang in the reverse
primer. The oligonucleotide design was set up for the gen-
eration of cohesive ends corresponding to those created by
the restriction enzymes SacI and KpnI as shown in Figure 2.
It should be noted that with two internal SacI and one
internal KpnI recognition sites, this DNA fragment cannot
be cloned accordingly into the multiple cloning site of the
vector using the conventional restriction-ligation strategy.
Table 2 Cloning efficiencies using a proofreading DNA
polymerase
Ligation reaction EndoV Number
of colonies
Fraction
positive
pBSK +Mitf PCR product + 997 97.5% (39/40)
pBSK +Mitf PCR product - 5 ND
Mitf PCR product + 0
pBSK 10 ND
pIRES2-EGFP + AmpR PCR product + 384 100%
pIRES2-EGFP 0
pUC19 +mRFP1 PCR product + 113 85.8%
pUC19 +mRFP1 PCR product - 26 100%
mRFP1 PCR product + 0
pUC19 0
Ligation reactions were set up using plasmid vector DNA linearized by restriction
endonuclease treatment. Column two indicates whether the PCR-generated insert
was treated with endonuclease V. pBSK denotes pBluescript II KS(+). Fractions of
positive clones were determined by red fluorescence (mRFP1 PCR product), growth
in the presence of ampicillin (AmpR PCR product) or colony PCR (Mitf PCR product,
40 clones tested), respectively. ND =not determined.
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in order to reduce the reaction time and the frequency
of PCR errors. Following treatment with 5 u E. coli
endonuclease V, purified insert DNA fragments were
used in five- or 10-fold molar ratios relative to digested
and dephosphorylated pBluescript II KS(+). Competent
E. coli XL-1 Blue and BL21 strains were used for trans-
formation of the ligation reactions. The five-fold molar
excess of insert DNA fragments yielded 137 or 444 col-
onies, respectively, while the 10-fold excess yielded 83
or 456 colonies, respectively. Consequently, no profound
differences were observed from the two different ratios of
insert to vector molecules used in the individual ligation
reactions. In order to detect the fraction of clones carrying
the Mitf target DNA fragment inserted into pBluescript II
KS(+) in correct orientation, a colony PCR assay was
performed with colonies of both strains. Oligonucleotides
Mitf-FL_f and VR2_r (Table 1) were used, with the first
being complementary to the insert DNA sequence and the
second to the vector backbone in reverse direction relative
to the expected insert orientation. All 19 colonies tested
were positive (data not shown), indicating the presence
of the Mitf coding sequence inside the target plasmid
in correct orientation. DNA sequencing of five additional
randomly picked clones was performed, each using flanking
forward and reverse primers. One clone showed a large
plasmid backbone deletion of approximately 1.9 kb. The
remaining four clones carried correct junction sites and the
expected insert. Despite the relatively large amplicon size
for a Taq-based PCR, two clones had full-length inserts free
of mutations. The cloned Mitf coding sequence of the other
two clones had two or four mutations, respectively.
High fidelity cloning
Although robust, primer extension reactions using Taq
DNA polymerase suffer from relatively low fidelity of the
enzyme, restricting the cloning of DNA fragments to a
maximum length of about 1.5 kb. As shown by Eckert
and Kunkel, improvements in fidelity can be reached
by optimization of the PCR conditions [54].
Cloning of even larger DNA fragments demands the use
of a DNA polymerase with proofreading capability, thus
3′-5′ exonuclease activity. Several polymerases of archeal
origin were reported to be unable to amplify deaminated
nucleotides efficiently [56]. We found the enzymes Q5
(formulated with or without an aptamer-based inhibitor for
hot start functionality), Phusion, PfuUltra II and Deep VentR
failing to amplify DNA fragments when dI-containing
oligonucleotide primers were used (data not shown).
However, with PfuTurbo Cx Hotstart, one exception was
found. This Pfu DNA polymerase mutant was engineered
to overcome uracil stalling. According to the manufac-
turer’s description, this enzyme possesses a fidelity equiva-
lent to that of the wild-type protein and allows generationof PCR products exceeding a length of 6 kb [57]. While all
other tested proofreading enzymes failed to generate PCR
products suitable for endonuclease V-mediated cloning,
all three types of recombinants (pIRES2-AmpR, pUC19-
mRFP1, pBSK-Mitf) were successfully created by using the
Pfu DNA polymerase mutant in place of the Taq enzyme.
Without PCR optimization, comparable numbers of col-
onies were obtained using a molar vector to insert ratio of
1:8 (as summarized in Table 2). Ligation reactions using
KpnI-linearized pIRES2-EGFP and PCR products treated
with E. coli EndoV yielded 384 ampicillin-resistant colonies.
Expression of mRFP1 was detected in 97 out of 113 clones,
equivalent to a cloning efficiency of 85.8%. An increased
molar vector to insert ratio of 1:10 yielded 170 colonies, of
which 153 (90%) were fluorescent. Significantly lower in
number, the origin of the 26 positive clones generated using
a ratio of 1:8 without EndoV treatment remains unknown.
Presumably, in vivo recombination events occurred.
The Mitf PCR product was successfully cloned into the
multiple cloning site of plasmid vector pBluescript II KS(+).
Transformation of ligation reactions containing only the
linearized plasmid vector yielded five colonies while the
addition of the EndoV-treated PCR products resulted in
997 cfu. With 816 cfu, increasing the molar insert to vector
fragment ratio to 10:1 did not result in a higher number of
transformants. Without EndoV treatment, transformation
of the corresponding ligation reaction resulted in only 10
colonies, demonstrating that deoxyinosine 3′ endonuclease
activity is a strict requirement for the cloning strategy to
work. Further analysis of the recombinants using col-
ony PCR indicated that from 39 clones, 38 carried the
Mitf coding sequence in correct orientation (Figure 5).
This corresponds to a cloning efficiency of 97.5%.
NC
1500 bp
NC
1500 bp
Figure 5 Colony PCR screening to detect successful cloning of Mitf. Presence of the Mitf coding region inside the plasmid vector pBluescript
II KS(+) in correct orientation detected by colony PCR and analytical gel electrophoresis. From 40 individually tested colonies, 39 were judged
positive as evident from the amplification of a DNA fragment (expected size: 1621 bp). Colonies from the same E. coli strain transformed with
plasmid DNA lacking the Mitf coding region served as negative control (NC).
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that a Pfu DNA polymerase mutant can achieve exponen-
tial DNA amplification in PCR using two deoxyinosine-
containing oligonucleotides. Gill et al. have reported
that the mutant enzyme V93Q can extend duplexes with
modified primers, while exponential amplification fails
when dGTP is replaced by dITP [58]. Using dI-containing
oligonucleotides, primer extension reactions with the wild-
type enzyme were reported to fail [44,59]. Using PfuUltra II
Fusion HS, we indeed observed no exponential amplifica-
tion (data not shown). Relative to Taq DNA polymerase,
the mutant Pfu enzyme proved more sensitive towards
high annealing temperatures. The target PCR product
yield was found to be optimal when the primer annealing
steps were performed at Tm - 3°C and decreased as soon
as Tanneal exceeded Tm (compare Figure 6). Only in onecase, nonspecific by-products were observed, namely
for the ampicillin resistance cassette PCR conducted
with Tanneal ≥ Tm + 3°C.
Conclusions
The developed method allows the creation of PCR frag-
ments carrying cohesive ends compatible to those of Type
II restriction endonucleases which create 4 bp 3′ over-
hangs, as demonstrated herein for four different restriction
enzyme recognition sites. To date, 21 enzymes of this type
are commercially available [60]. The key advantage of our
approach is the independence of the insert DNA sequence,
which can - in contrast to the conventional cloning method
- internally carry the recognition sequences of the restric-
tion enzymes used for the digestion of the target plasmid
vector. Consequently, only the approximate insert length
1200 bp
800 bp
-1 +1 +3 +5-4 -2 Tm +2
A B C
1200 bp
Tm +3 +6
Figure 6 Insert DNA fragment generation using a proofreading DNA polymerase. PfuTurbo Cx Hotstart polymerase was used for PCR
amplification of insert DNA fragments using two deoxyinosine-containing oligonucleotides. Analytical agarose gel electrophoresis was performed
with PCR products comprising the ampicillin resistance cassette (1114 bp, A), the mRFP1 reporter device (830 bp, B), and the Mitf coding
sequence (1270 bp, C). Annealing temperatures which were used for PCR cycling are indicated relative to Tm for each lane.
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sequences (for primer design) must be known. The devel-
oped method is straightforward and requires only minimal
amounts of template DNA, e.g. 1 ng plasmid DNA or a
single E. coli colony, for insert generation. With sufficient
amounts of target plasmid vector at hand, all cloning steps
can be performed in a single day finished by overnight
incubation of transformed E. coli cells.
In contrast to other cloning strategies (e.g. In-Fusion
cloning) [37], cohesive terminal sequences are created
via primer overhangs only four nucleotides in length. As a
result, the PCR-primers used for insert DNA generation
remain short, minimizing the chance for secondary struc-
ture and primer-dimer formation as well as synthesis errors
to occur. Including a single deoxyinosine residue, this type
of modification is cost-efficient and available from commer-
cial suppliers. Even at small synthesis scale, shipped primer
amounts are good for several hundred PCRs. Therefore,
the method is particularly cost-effective when primers can
be reused, e.g. for cloning of individual mutants in the con-
text of libraries. By employing two different overhangs, no
multiple insertions were observed and cloning was dir-
ectional as anticipated. Consequently, the developed
method is most suitable to use when no appropriate pair
of Type II restriction endonucleases for the conventional
restriction-ligation strategy is at hand or available. As a re-
sult, a reduced number of such enzymes has to be
maintained in the laboratory. The new strategy is also
particularly suited when ligation-independent cloning
(LIC) methods and techniques based on homologous re-
combination fail, for instance when the required homolo-
gous regions cannot be created via PCR. Although in
principle possible, we recommended to avoid PCR-
amplification of the vector DNA, as it is prone to introduce
PCR errors. For the same reason, cloned insert sequences
should be verified by sequencing.Assuming an equal incorporation probability for all four
canonical nucleotides when the DNA polymerase encoun-
ters the dI residue on the template strand, one out of four
created insert termini can be ligated to a cohesive vector
DNA end (compare Figure 2). It is thus conceivable that
the ligation efficiency benefits from even higher molar
insert to vector ratios. Based on our experiences, however,
ratios between 5:1 and 8:1 are optimal. It should be
emphasized that for all plasmid clones described within
this study, the created ligation sites presented an exact
match to the overhang of the vector fragment. Evidently,
only PCR amplicons having precisely matching cohe-
sive ends hybridize efficiently with vector molecules.
Consequently, inserts which contained mismatches at the
position complementary to the dI residue were not ligated
to the linearized vector at detectable frequencies. Note
that ligation conditions were chosen according to the
manufacturer’s recommendation for T4 DNA ligase
and cohesive ends. Conditions potentially favoring the
formation of wrong pairings (e.g. low temperatures)
should be avoided. While sufficient colony numbers were
obtained in all cases, it should be noted that competent
cells with relatively low transformation efficiency were
used intentionally.
Although the terminal transferase activity of Taq DNA
polymerase [61] could potentially cause ligation prob-
lems, additional nucleotides flanking the ligation sites
or mutations therein were never observed. Inexpensive
and robust, this enzyme is recommended for cloning of
insert sequences up to 500 bp in length. Compatibility
with the PfuTurbo Cx Hotstart DNA polymerase relieves
the limitations generated by the relatively low fidelity of
the Taq enzyme and greatly expands the application
range of the cloning method. It is further possible that
the absence of terminal transferase activity leads to higher
cloning efficiencies compared to Taq polymerase.
Baumann et al. BMC Biotechnology 2013, 13:81 Page 9 of 11
http://www.biomedcentral.com/1472-6750/13/81With its broad buffer compatibility, E. coli endo-
nuclease V allows its combined use with more than 200
commercially available restriction enzymes [9]. This
could further expand the range of cloning options by
generating one cohesive end via EndoV and one via a
Type II restriction endonuclease. In addition, this en-
zyme can be heat-inactivated and requires an incubation
temperature of 37°C in contrast to the highly stable
Thermotoga maritima enzyme. Since a fill-in reaction by
the DNA polymerase cannot take place, a direct addition
of endonuclease V to the PCR mixture after thermocycling
is also conceivable.
Methods
Plasmids and strains
Target plasmid vectors suitable for propagation in E. coli
were pUC18 and pUC19 [62], pIRES2-EGFP (Clontech,
Mountain View, CA, USA) and pBluescript II KS(+)
[GenBank: X52327.1]. pSB1C3 and the RFP coding device
BBa_J04450 were obtained from the Registry of Standard
Biological Parts [63]. pAR200d-Mitf_FL is a derivative
of pQE16 (Qiagen, Hilden, Germany) containing the
coding sequence of the Mus musculus microphthalmia-
associated transcription factor (Mitf)[GenBank: Z23066.1].
Competent Escherichia coli XL-1 Blue (Stratagene; now
Agilent Technologies, Böblingen, Germany) and BL21-cells
(Novagen, Darmstadt, Germany) were prepared by standard
CaCl2 protocol. Transformation efficiencies determined
as cfu per μg pUC18 plasmid DNA reached 1–3 × 106
for XL-1 Blue and 3–4 × 106 for BL21.
Design of deoxyinosine-containing primers
All oligonucleotides used in this study were obtained from
Sigma-Aldrich (Taufkirchen, Germany) in desalted quality
without further purification. Primers were dissolved in
water and stored at -20°C. All Tm values reported in
this study correspond to theoretical values determined for
complementary regions by the nearest-neighbor method
using OligoCalc [64] with default parameters. In order to
create 3′ protruding ends by endonuclease V treatment of
the PCR products, a single deoxyinosine residue was placed
at the third position of the primer 5′ end (compare Figure 1).
DNA segments complementary to the ends of the template
molecule were designed to reach Tm values of ≥ 53°C.
PCR-based amplification of target DNA fragments
Taq DNA polymerase and dNTP mix were obtained
from New England Biolabs (Frankfurt am Main, Germany).
The supplied Standard Taq Reaction Buffer containing
1.5 mM MgCl2 was used. Reactions with a total volume of
50 μL further contained 50 μM of each dNTP, 0.2 μM
each primer, 1 ng template DNA and 2.5 u enzyme.
Thermocycling was performed using a Mastercycler gradi-
ent (Eppendorf, Hamburg, Germany) with a heated lid andthe following common parameters: initial denaturation 95°C
30 s; amplification (95°C 25 s, Tanneal (as calculated)
25 s, 68°C 60 s per kb) × 19–31 cycles; final extension
68°C 3 min. Unless stated otherwise, Tanneal equals to
the calculated Tm value minus 3°C. For colony PCR,
small samples of E. coli colonies served as the template
DNA source. PfuTurbo Cx Hotstart DNA polymerase
(Agilent Technologies, Böblingen, Germany) was used
for high fidelity PCR. Reactions contained the supplied
buffer and final concentrations of 50 μM each dNTP,
0.2 μM each primer, 1 ng template DNA and 2.5 u of
enzyme. Thermocycling was performed using the following
parameters: 95°C 2 min; (95°C 20 s, Tanneal 20 s, 72°C
60 s per kb) × 25 cycles; 72°C 3 min. PfuUltra II Fusion
HS DNA polymerase was purchased from Agilent
Technologies (Böblingen, Germany). The DNA polymer-
ases Q5 High-Fidelity, Q5 Hot Start High-Fidelity, Deep
VentR and Phusion High-Fidelity were purchased from
New England Biolabs (Frankfurt am Main, Germany). DNA
concentrations were determined using a NanoDrop 2000
micro-volume UV-Vis spectrophotometer (Thermo Fisher
Scientific, Schwerte, Germany). Agarose gels for PCR
product analysis or purification, respectively, were prepared
using Agarose Standard (Carl Roth GmbH, Karlsruhe,
Germany) and TAE buffer. GeneRuler DNA ladder mix
(Thermo Fisher Scientific, St. Leon-Rot, Germany) was
used as a size marker. DNA was stained using GelRed
(Biotium Inc., Hayward, CA, USA). PCR products were
visualized under UV transillumination. Pictures were
taken using an EOS 1100D Digital SLR camera (Canon,
Krefeld, Germany) equipped with a Hoya K2 HMC
filter (Hapa-Team, Eching, Germany). In order to fa-
cilitate the visual detection of faint bands, adjustments
in greyscale levels were performed on the entire digital
image. Silica membrane-based PCR product purifica-
tion was performed using a NucleoSpin Extract II kit
(Machery-Nagel, Düren, Germany).
Endonuclease V treatment
Escherichia coli or Thermotoga maritima endonuclease
V (EndoV) were obtained from New England Biolabs
(Frankfurt am Main, Germany) or Thermo Fisher Scientific
(St. Leon-Rot, Germany), respectively. DNA treatments
were performed in the supplied buffers for 45 min at 37°C
or 60°C, respectively.
Ligation with plasmid vector fragments
Plasmid vector DNA fragments were produced by re-
striction endonuclease treatment. All restriction enzymes
(EC 3.1.21.4) were of Type IIP [65] and were obtained from
New England Biolabs (Frankfurt am Main, Germany),
as High Fidelity (HF) versions if available. Reactions
were performed at 37°C for at least 2 h using the supplied
NEBuffer 4 and BSA solution. Vector DNA fragments
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using a NucleoSpin Extract II kit (Machery-Nagel, Düren,
Germany). Antarctic Phosphatase from New England
Biolabs (Frankfurt am Main, Germany) was used to release
the terminal 5′ phosphate groups; incubation and heat
inactivation were performed as recommended by the
manufacturer. Without further purification, the reaction
products were used for ligation reactions. Different molar
ratios of insert to vector DNA as well as 1 Weiss unit of T4
DNA Ligase and the supplied buffer from Thermo Fisher
Scientific (St. Leon-Rot, Germany) were used. With a total
volume of 10 μL, the reactions were incubated for 30 min at
room temperature (20–25°C). A 2 μL sample was used for
E. coli transformation (50 μL cell suspension) by heat shock.
Analysis of transformants
The presence of a functional ampicillin resistance cassette
(AmpR) was tested by transferring freshly transformed
E. coli cell suspensions onto LB agar plates supplemented
with 50 μg/mL ampicillin in addition to either 50 μg/mL
kanamycin (pIRES2-EGFP vector backbone) or 25 μg/mL
chloramphenicol (pSB1C3 vector backbone), respectively.
Colony forming units (cfu) were determined as described
[66] using ImageJ (National Institutes of Health, Bethesda,
MD, USA). Expression of mRFP1 [53] from the RFP
coding device was visible to unaided eyes under day light.
Epi-illumination pictures of red fluorescent colonies were
taken by using 505 nm cyan LEDs (Winger Electronics,
Dessau-Roßlau, Germany) and an EOS 1100D Digital
SLR camera (Canon, Krefeld, Germany) equipped with
a UV-filter.
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